SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company. It engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. The company was founded on October 7, 2004 and is headquartered in Tampa, FL.

Akari Therapeutics Plc - ADR

Akari Therapeutics

Akari Therapeutics is capturing significant market attention following positive preclinical data for its ADC candidate AKTX-101 in treating KRAS-mutated pancreatic cancer. The community is actively debating the stock's potential for a parabolic run, with many investors focusing on the company's micro-float status and comparing recent moves to previous high-volatility momentum plays.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp (BULL) is seeing heightened volatility and intense social media discussion as traders speculate on potential earnings leaks and manipulation ahead of the company's latest quarterly report. The community remains deeply divided, with bulls pointing toward the firm's growth in customer assets and upcoming regulatory changes as long-term catalysts, while bears focus on rising operating expenses and persistent downward pressure on the share price.

Workday, Inc. engages in the provision of development of enterprise cloud applications for finance and human resources. It delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Workday Inc - Ordinary Shares - Class A

Workday Inc

Workday is trending after reporting strong quarterly results that surpassed earnings and revenue expectations, helping to alleviate concerns regarding the durability of enterprise software demand. The community is actively discussing the company's progress in AI integration and whether these results signal a stabilization for the broader software sector against the rising narrative of AI-driven disruption.

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

Zoom Video Communications, Inc.

Zoom is trending after reporting a quarterly earnings beat and raising its full-year guidance, bolstered by strong enterprise demand and a new $1 billion share buyback authorization. Community sentiment remains split, with bulls pointing to the company's robust cash position and strategic AI investments as a value opportunity, while bears remain skeptical of long-term growth prospects due to intense competition and stagnant price action.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

Deckers Outdoor Corp. is capturing significant market attention as investors weigh the company's strong brand performance from HOKA and UGG against concerns over supply chain headwinds and institutional downgrades. While community sentiment remains divided between bulls focused on solid revenue growth and buyback initiatives and bears concerned about weakening leadership and sector-wide competitive pressure, market participants are bracing for upcoming earnings to provide clarity on the stock's future trajectory.

UP Fintech Holding Ltd. is an online brokerage firm that focuses on global investors. It provides an online trading platform that enables investors to trade in equities and other financial instruments on multiple exchanges around the world. The firm offers products and services, as well as a user experience to customers through its mobile first strategy. The company was founded by Tian Hua Wu in June 2014 and is headquartered in Singapore.

UP Fintech Holding Ltd - ADR

UP Fintech is facing significant volatility as investors react to potential regulatory penalties in China, fueling concerns about the stability of the company's overseas brokerage operations. While some traders view the resulting pullback as a buying opportunity given the company's strong revenue growth and client account expansion, others are bracing for further downside amid broader skepticism toward Chinese ADRs.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is generating significant market buzz as the company launches its R2 configurator and prepares for upcoming customer deliveries, drawing strong interest from investors and the broader EV community. While social media sentiment remains divided between hopeful bulls focused on production ramps and strategic partnerships and skeptical bears concerned about stock performance and capital burn, the stock remains a high-engagement topic as stakeholders wait for concrete delivery and order data to potentially spark a technical reversal.

Futu Holdings Ltd. engages in the provision of digitalized financial services. It offers securities brokerage and wealth management products. The company was founded by Leaf Hua Li in December 2007 and is headquartered in Hong Kong.

Futu Holdings Ltd - ADR

Futu Holdings is trending as shares face heavy downward pressure following reports of a two-year regulatory crackdown in China targeting overseas trading platforms. The community is actively debating whether to buy the dip as a value play or avoid the stock entirely due to persistent geopolitical risks and regulatory uncertainty.

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.

Olema Pharmaceuticals Inc

Olema Pharmaceuticals is surging as the success of a competitor's late-stage trial for a similar breast cancer drug class validates the potential of its own pipeline and fuels intense speculation about a future buyout. Community members are actively debating the sustainability of the rally versus risks like dilution, while institutional ownership and the potential for a short squeeze remain key focal points.

Groupon, Inc. engages in the global scaled two-sided marketplace that connects consumers to merchants. It operates through the North America and International geographical segments. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell in October 2008 and is headquartered in Chicago, IL.

Groupon Inc

Groupon is seeing a surge in investor attention as the community identifies a classic short squeeze setup, fueled by high short interest, a shrinking float due to aggressive share buybacks, and anticipation ahead of earnings. Traders are actively discussing the stock's potential for parabolic movement, drawing comparisons to other high-profile squeeze plays while monitoring key technical resistance levels for a potential breakout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GSK Stock Declines 9% in a Month: Time to Buy, Hold or Exit?

GSK shares slide after Q1 despite earnings and sales beats, as investors weigh slowing legacy drug sales against strong Specialty Medicines growth.

Ralph Baric And UNC's Biodefense Contract Racket Exposed

Ralph Baric And UNC's Biodefense Contract Racket Exposed Authored by Paul D. Thacker via The DisInformation Chronicle, DLA Piper wants to get you, I was told, from a source in DC over the weekend...

GSK Targets China's Hepatitis B Market Through New Deal

GSK partnered with Sino Biopharmaceutical to advance hepatitis B drug bepirovirsen in China while launching its final buyback tranche.read more...

GSK Launches Final GBP 0.18 Bln Tranche Of GBP 2 Bln Share Buyback

(RTTNews) - GSK plc (GSK, GSK.L, GS71.DE), on Monday announced the commencement of the fifth and final tranche of its 2 billion pounds share buyback program, covering up to about 0.18 billion pounds...

GILD Beats Q1 Earnings and Sales Estimates, Lowers '26 EPS View

GILD beats Q1 estimates as HIV and Trodelvy sales rise, but shares slip after the company cuts its 2026 EPS outlook.

GSK (LON:GSK) Receives Hold Rating from Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and issued a GBX 1,900 price target on shares of GSK in a research note on Wednesday...

GSK (LON:GSK) Given New GBX 2,100 Price Target at Citigroup

Citigroup reduced their price objective on GSK from GBX 2,250 to GBX 2,100 and set a 'neutral' rating for the company in a report on Wednesday...

Tempus AI's Big Pharma AI Partnerships Are Getting Bigger And Stickier

Tempus AI (TEM) Q1 results: Revenue up 36.1% to $348.1M, beating estimates. TEM raises 2026 outlook amid strong AI & diagnostic demand.read more...

129,513 Shares in GSK PLC Sponsored ADR $GSK Acquired by PFA Pension Forsikringsaktieselskab

PFA Pension Forsikringsaktieselskab purchased a new position in shares of GSK PLC Sponsored ADR (NYSE:GSK - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 129,513 shares of the pharmaceutical company's...

SMMT Q1 Loss Narrower Than Expected, Stock Down on Ivonescimab Setback

Summit Therapeutics posts narrower Q1 loss but stock plunges 25% after ivonescimab setback, raising concerns over its late-stage cancer pipeline progress.

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Current Price	$51.53
Prev Close	$50.78
Open	$50.84
Dividend Yield	3.56%
50-Day Moving Average	$53.80
Beta	0.30
Avg. Volume	4.33M
PE Ratio	13.29

52-Week High	$61.70
52-Week Low	$35.45
Market Capitalization	$102.85B
EPS (Annual)	$3.72
Price to Book	4.40
Revenue Per Employee	$644,088.53

GSK
Glaxosmithkline plc - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest GSK News

GSKGlaxosmithkline plc - ADR